|
1
|
Lin YT, Huang AC, Kuo CL, et al: Induction
of cell cycle arrest and apoptosis in human osteosarcoma U-2 OS
cells by Solanum lyratum extracts. Nutr Cancer. 65:469–479.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liang CZ, Zhang X, Li H, et al: Gallic
acid induces the apoptosis of human osteosarcoma cells in vitro and
in vivo via the regulation of mitogen-activated protein kinase
pathways. Cancer Biother Radiopharm. 27:701–710. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cho HJ, Lee TS, Park JB, et al: Disulfiram
suppresses invasive ability of osteosarcoma cells via the
inhibition of MMP-2 and MMP-9 expression. J Biochem Mol Biol.
40:1069–1076. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang G, Mills L and Worth LL: Expression
of human glutathione S-transferase P1 mediates the chemosensitivity
of osteosarcoma cells. Mol Cancer Ther. 6:1610–1619. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang B, Shi ZL, Liu B, Yan XB, Feng J and
Tao HM: Enhanced anticancer effect of gemcitabine by genistein in
osteosarcoma: the role of Akt and nuclear factor-κB. Anticancer
Drugs. 21:288–296. 2010.PubMed/NCBI
|
|
6
|
Posthumadeboer J, van Egmond PW, Helder
MN, et al: Targeting JNK-interacting-protein-1 (JIP1) sensitises
osteosarcoma to doxorubicin. Oncotarget. 3:1169–1181.
2012.PubMed/NCBI
|
|
7
|
Zhang Y, Wei RX, Zhu XB, Cai L, Jin W and
Hu H: Tanshinone IIA induces apoptosis and inhibits the
proliferation, migration, and invasion of the osteosarcoma MG-63
cell line in vitro. Anticancer Drugs. 23:212–219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu HY, Lin TK, Kuo HM, et al:
Phyllanthus urinaria induces apoptosis in human osteosarcoma
143B cells via activation of Fas/FasL- and mitochondria-mediated
pathways. Evid Based Complement Alternat Med. 2012:1–13. 2012.
|
|
9
|
Teh BS, Chen P, Lavin MF, Seow WK and
Thong YH: Demonstration of the induction of apoptosis (programmed
cell death) by tetrandrine, a novel anti-inflammatory agent. Int J
Immunopharmacol. 13:1117–1126. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lai YL, Chen YJ, Wu TY, et al: Induction
of apoptosis in human leukemic U937 cells by tetrandrine.
Anticancer Drugs. 9:77–81. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong Y, Yang MM and Kwan CY: In vitro
inhibition of proliferation of HL-60 cells by tetrandrine and
coriolus versicolor peptide derived from Chinese medicinal herbs.
Life Sci. 60:PL135–140. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cho HS, Chang SH, Chung YS, et al:
Synergistic effect of ERK inhibition on tetrandrine-induced
apoptosis in A549 human lung carcinoma cells. J Vet Sci. 10:23–28.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He BC, Gao JL, Zhang BQ, et al:
Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor
growth of human colorectal cancer. Mol Pharmacol. 79:211–219.
2011.
|
|
14
|
Yoo SM, Oh SH, Lee SJ, et al: Inhibition
of proliferation and induction of apoptosis by tetrandrine in HepG2
cells. J Ethnopharmacol. 81:225–229. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei J, Liu B, Wang L, Qian X, Ding Y and
Yu L: Synergistic interaction between tetrandrine and
chemotherapeutic agents and influence of tetrandrine on
chemotherapeutic agent-associated genes in human gastric cancer
cell lines. Cancer Chemother Pharmacol. 60:703–711. 2007.
View Article : Google Scholar
|
|
16
|
Meng LH, Zhang H, Hayward L, Takemura H,
Shao RG and Pommier Y: Tetrandrine induces early G1 arrest in human
colon carcinoma cells by down-regulating the activity and inducing
the degradation of G1-S-specific cyclin-dependent kinases and by
inducing p53 and p21Cip1. Cancer Res. 64:9086–9092. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Wang C, Wang H, Wang K, Du Y and
Zhang J: Combination of tetrandrine with cisplatin enhances
cytotoxicity through growth suppression and apoptosis in ovarian
cancer in vitro and in vivo. Cancer Lett. 304:21–32. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu C, Gong K, Mao X and Li W: Tetrandrine
induces apoptosis by activating reactive oxygen species and
repressing Akt activity in human hepatocellular carcinoma. Int J
Cancer. 129:1519–1531. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Su B, Liu R, Wu D and He D:
Tetrandrine induces apoptosis and triggers caspase cascade in human
bladder cancer cells. J Surg Res. 166:e45–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lima RT, Busacca S, Almeida GM, Gaudino G,
Fennell DA and Vasconcelos MH: MicroRNA regulation of core
apoptosis pathways in cancer. Eur J Cancer. 47:163–174. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fernandez-Luna JL: Regulation of
pro-apoptotic BH3-only proteins and its contribution to cancer
progression and chemoresistance. Cell Signal. 20:1921–1926. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ
and Tao HM: Matrine induces caspase-dependent apoptosis in human
osteosarcoma cells in vitro and in vivo through the upregulation of
Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother
Pharmacol. 69:317–331. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ito Y, Pandey P, Sporn MB, Datta R,
Kharbanda S and Kufe D: The novel triterpenoid CDDO induces
apoptosis and differentiation of human osteosarcoma cells by a
caspase-8 dependent mechanism. Mol Pharmacol. 59:1094–1099.
2001.PubMed/NCBI
|
|
24
|
Oh SH and Lee BH: Induction of apoptosis
in human hepatoblastoma cells by tetrandrine via caspase-dependent
Bid cleavage and cytochrome c release. Biochem Pharmacol.
66:725–731. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shukla RK, Kumar A, Gurbani D, Pandey AK,
Singh S and Dhawan A: TiO2 nanoparticles induce
oxidative DNA damage and apoptosis in human liver cells.
Nanotoxicology. 7:48–60. 2013.
|
|
26
|
Kaseta MK, Khaldi L, Gomatos IP, et al:
Prognostic value of bax, bcl-2, and p53 staining in primary
osteosarcoma. J Surg Oncol. 97:259–266. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao X, Bennett RL and May WS: c-Myc and
caspase-2 are involved in activating Bax during cytotoxic
drug-induced apoptosis. J Biol Chem. 283:14490–14496. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schmitz I, Kirchhoff S and Krammer PH:
Regulation of death receptor-mediated apoptosis pathways. Int J
Biochem Cell Biol. 32:1123–1136. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo X, Budihardjo I, Zou H, Slaughter C
and Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome
c release from mitochondria in response to activation of
cell surface death receptors. Cell. 94:481–490. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu X, Kim CN, Yang J, Jemmerson R and
Wang X: Induction of apoptotic program in cell-free extracts:
requirement for dATP and cytochrome c. Cell. 86:147–157.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang K, Yin XM, Chao DT, Milliman CL and
Korsmeyer SJ: BID: a novel BH3 domain-only death agonist. Genes
Dev. 10:2859–2869. 1996. View Article : Google Scholar : PubMed/NCBI
|
